Welcome: Guest | Site Use Options | Register | Login |


Profile last edited on: 2/1/2016
16730 Calle De Catalina
Pacific Palisades, CA 90272
  (310) 309-9036
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
AADi, LLC, a clinical stage biopharmaceutical company focused on treating diseases uniquely suited for nanotechnology approaches and headed by an inventor of ABRAXANE and the nab technology platform.. In 2014, the firm achieved an important in-licensing from Celgene AADi's lead product is ABI-009, a nanoparticle albumin-bound mTOR inhibitor based on sirolimus or rapamycin, also known as nab-rapamycin. The focus is on development of the full potential of the albumin-bound mTOR inhibitor in diseases where the mTOR inhibitors have not or cannot be effectively exploited due to problems of effective drug delivery, safety or effective targeting to the disease site.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Investigation of a Nanoparticle Albumin-Bound Mtor Inhibitor, Nab-Rapamycin for T

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920